TD Cowen 46th Annual Health Care Conference March 3, 2026 3:10 PM ESTCompany ParticipantsEric BrownGiacomo Salvadore - Chief ...
Using rodent and cellular models, the researchers showed that tanycytes take up tau from the CSF and release it into ...
A first-in-human trial shows the feasibility and safety of delivering placenta-derived stem cells during prenatal ...
To date, there are no regenerative stem cell products commercially available to treat diseases in utero. In-utero treatment ...
“Latent herpes viruses have the potential to reactivate in people living with HIV which can lead to neuroinflammation and impact long-term brain health,” said Shirin Mazumder, MD, infectious diseases ...
BLA resubmitted to U.S. FDA in January 2026; Company expects up to six-month review period per FDA guidelines NOVATO, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. today ...
Data represents up to 8.5 years of follow-up and are consistent across age, dose, and genotype BLA resubmitted to U.S. FDA in January 2026; Company expects up to six-month review period per FDA ...
A collaborative research team has developed the world's first AI-based optical diagnostic platform that enables rapid and accurate differentiation—within minutes—between ordinary nasal secretion and ...
Background: Macrophages play a pivotal role in cardiac development, homeostasis and disease. After myocardial infarction (MI), macrophages expand and regulate inflammation, repair, angiogenesis and ...
eMultiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results